FDA Inspection 1020421 — Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. — FEI 2243471

The FDA completed an inspection of Roche Molecular Systems, Inc. on Jul 19, 2017 in Branchburg, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 19, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.